Trial Profile
Phase I trial of weekly teriparatide [ZP-PTH] for the treatment of postmenopausal osteoporosis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Oct 2015
Price :
$35
*
At a glance
- Drugs Teriparatide (Primary)
- Indications Postmenopausal osteoporosis
- Focus Adverse reactions
- Sponsors Zosano Pharma
- 01 Oct 2015 New trial record